Huma: Summary

Huma

Healthcare, Digital Health

Huma's remote patient monitoring platform advances connected care for patients and accelerates research and therapies

Longer, fuller lives with digital-first care and research

Remote Patient Monitoring, Decentralized Clinical Trials, Companion Apps

Huma's platforms can be used to support hospitals and clinics, patients, and research and therapies

Huma's platforms can almost double clinical capacity and reduce readmission rates by >30%, and have received FDA Class II clearance for their disease agnostic SaMD Platform

N/A

Huma's platforms have been proven to have a sustainable impact for patients, can almost double clinical capacity, and have received FDA Class II clearance

Huma positions itself as a digital-first care and research company that aims to help people live longer, fuller lives

Huma's platforms are targeted towards hospitals and clinics, patients, and research and therapies

Request a meeting, Find out more, Request a meeting

Huma has partnerships with major governments, hospital groups, universities, life science and technology companies, and has been recognized as a global innovator and one of 'Europe's 1000 Fastest Growing Companies of 2023' by Financial Times.

Impactful, Innovative, Collaborative

Huma has received FDA Class II clearance for their SaMD Platform and has been recognized with awards and accolades such as the Prix Galien award for digital health and being selected as one of 'The Most Important Healthcare Design of 2021' by Fast Company

Huma differentiates itself from competitors by offering a comprehensive platform for remote patient monitoring, decentralized clinical trials, and companion apps, and by receiving FDA Class II clearance for their SaMD Platform

Huma positions itself as a leader in digital-first care and research, with a focus on improving patient outcomes and advancing therapies